跳至主要内容
临床试验/KCT0007246
KCT0007246尚未招募未知

Comparative effects of propofol and remimazolam on US-guided radiofrequency ablation of hepatic neoplasm under monitored anesthesia care

Asan Medical Center0 个研究点目标入组 44 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20?(Year) 至 79?(Year)(—)
性别
All

入选标准

  • 1) Patients planning to undergo ultrasound-guided liver radiofrequency ablation under supervised anesthesia
  • 2) Adult male and female patients between the ages of 20 and 80
  • 3) Patients who voluntarily consented in writing to participate in this clinical trial
  • 4) Patients falling under ASA classification 1-2

排除标准

  • 1) If the patient does not consent to participate in the study
  • 2) If you have previously been allergic to propofol or remimazolam
  • 3) If the modified Allen's test is negative
  • 4) In case of serious cardiovascular or cerebrovascular disease
  • 5) If you have serious lung disease
  • 6) In case of severe liver cirrhosis
  • 7) Other patients determined by the researcher to be inappropriate

研究者

相似试验